ADOC-U Stock Price, News & Analysis

adoc-u

Company Description

ADOC-U (Nasdaq: adoc-u) is a publicly traded company.

This page provides a comprehensive overview of adoc-u stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

August 12, 2022

0.00%

Edoc Acquisition Corp. Announces Termination of Merger Agreement with Calidi Biotherapeutics, Inc.

acquisition

August 12, 2022

0.00%

Edoc Acquisition Corp. Announce Postponement of Special Meeting of Shareholders to Extend the Deadline to Consummate an Initial Business Combination

acquisition

August 4, 2022

0.00%

Edoc Acquisition Corp. Reminds Shareholders to Vote and Announces Additional Contribution for Extension Amendment

acquisition

February 7, 2022

0.00%

Edoc Acquisition Corp. Reminds Shareholders to Vote in Favor of Extension Amendment

acquisition

February 2, 2022

0.00%

Calidi Biotherapeutics and Edoc Acquisition Corp. Agree to Merge and Create a Publicly Listed, Clinical-Stage Biotechnology Company Utilizing Stem Cell-Based Platforms to Revolutionize Oncolytic Virotherapies

acquisition

November 15, 2021

0.00%

EDOC Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination

acquisition

ADOC-U has 7 recent news articles. Key topics include acquisition. View all adoc-u news →

SEC Filings

View All

No SEC filings available for adoc-u.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months